Some years later, MSLN was revealed as broadly overexpressed in many others cancer indications, including squamous cell carcinomas of the esophagus, pancreas, lung, stomach, bile ducts, colorectal, and breast cancer, where its expression correlates with a worse prognosis [25,26,27,28]. The gene discussed is MSLN; the disease is breast carcinoma.